Tuesday, December 31, 2024

December 31, 2024 at 05:34PM CMC and GMP Guidances

This page lists CMC and GMP Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/RyiT8dx

Monday, December 30, 2024

December 30, 2024 at 09:51PM ACAM2000

ACAM2000 is a product approval indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7xstjWp

Friday, December 27, 2024

December 27, 2024 at 09:46PM FDA Roundup: December 27, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/u7TyKB4

December 27, 2024 at 05:38PM Combined Food and Drug Administration and Sponsor Oncologic Drugs Advisory Committee Briefing Document

Combined Food and Drug Administration and Sponsor Oncologic Drugs Advisory Committee Briefing Document

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/TrN0SM4

December 27, 2024 at 03:47PM Clinical Guidances

This page lists Clinical Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Hw3KxFO

Thursday, December 26, 2024

December 26, 2024 at 07:20PM MRESVIA

Rolling BLA (Part 1 of 2) - Active immunization for the prevention of lower respiratory tract disease (LRTD) and acute respiratory disease (ARD) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older.


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0p9sylY

Friday, December 20, 2024

December 21, 2024 at 12:10AM FDA Rare Disease Innovation Hub

FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and connectivity between CBER and CDER with the goal of ultimately improving outcomes for patients.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/E8qwdgM

December 20, 2024 at 08:28PM FDA Roundup: December 20, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6xVydHi

December 20, 2024 at 03:25PM FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities

FDA approved Symvess, the first acellular tissue engineered vessel for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MflsO6S

Thursday, December 19, 2024

December 19, 2024 at 10:21PM Executive Order 14017 on America’s Supply Chains

Updates on recommendations to help shore up the U.S. pharmaceutical supply chain, as directed by Executive Order 14017 on America’s Supply Chains

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/j60BX4c

December 19, 2024 at 01:26PM Approved Cellular and Gene Therapy Products

Listing of licensed and approved products from the Office of Therapeutic Products (OTP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7hQPs9i

December 18, 2024 at 11:00PM Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays

Links to the different types of Donor Screening Assays. A table for each assay is provided with detailed information such as tradename, infectious agent, format, specimen, use, manufacturer, approval date, and STN.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/QESG9RA

December 18, 2024 at 01:20PM Healthcare Providers (Biologics)

Resources for Healthcare Providers on biological products.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5Jl9m2z

Tuesday, December 17, 2024

December 17, 2024 at 11:36PM Fluzone and Fluzone High-Dose

Product approval information for Influenza Virus Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KJUbmHu

December 17, 2024 at 10:20PM FDA Roundup: December 17, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jH3kObF

December 17, 2024 at 09:57PM Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic

This guidance provides recommendations to industry regarding postmarketing adverse event reporting for drugs, biologics, medical devices, and dietary supplements during a pandemic.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3Wvkeni

December 17, 2024 at 08:56PM FDALabel: Full-Text Search of Drug Product Labeling

FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 150,000 labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rt7polU

December 17, 2024 at 02:41PM Global Unique Device Identification Database (GUDID)

Provides information necessary for submitting data to the Global Unique Device Identification Database (GUDID). Primarily intended for device labelers.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/JUxV9Cb

Monday, December 16, 2024

December 16, 2024 at 10:22PM Animal Rule Information

Learn more about the Animal Rule which may be used to grant marketing approval of certain products when human challenge studies are not ethical and human efficacy studies have not been feasible.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tNMs9jY

December 16, 2024 at 05:07PM Facts About COVID-19 Vaccines

Facts about COVID-19 vaccines, including ingredients, safety and more

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/b71lihq

Friday, December 13, 2024

December 13, 2024 at 10:35PM 2024 CBER Patient and Care Partner Listening Meetings

Gene therapy trials inform risks & benefits for informed decisions. Long-term follow-up crucial for safety & durability assessment.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/sTGAlFD

December 13, 2024 at 08:50PM eSubmitter Application History

History of all updates to the application software in reverse chronological order by version number

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/uWqrh2O

December 13, 2024 at 04:44PM Standards Development for Regenerative Medicine Therapies

Section 3036 of the 21st Century Cures Act refers to the development of standards for regenerative medicine therapies, including products designated regenerative medicine advanced therapies.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/89iXmSu

December 13, 2024 at 03:05PM COVID-19 Vaccines

FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Ad6WkxY

Thursday, December 12, 2024

December 12, 2024 at 09:22PM PAHO/WHO Collaborating Center

CBER has been a Pan American Health Organization (PAHO)/World Health Organization (WHO) Collaborating Center for Biological Standardization since 1998, formalizing its commitment to support the work of WHO after decades of scientific contributions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rydJhbR

December 12, 2024 at 03:34PM FDA Voices

Insights from FDA leadership and experts into the agency's work on policy, consumer safety & enforcement, medical products, food, & tobacco.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dQG6DKW

Wednesday, December 11, 2024

December 11, 2024 at 11:42PM Biologics Electronic Reading Room (eFOIA)

The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/dGxWquB

December 11, 2024 at 10:37PM Meeting 2: Patient and Care Partner Perspectives on Early Enrollment into Gene Therapy Clinical Trials for Rare Diseases

Gene therapy trials inform risks & benefits for informed decisions. Long-term follow-up crucial for safety & durability assessment.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ywXvH4s

December 11, 2024 at 04:24PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Public Engagement Staff.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/y6chFrP

December 11, 2024 at 03:12PM Webinars and Outreach

CBER sponsored webinars for public and industry.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/t7qcEaS

Tuesday, December 10, 2024

December 10, 2024 at 10:50PM Public Webinar: FDA Review of Biologics License Applications for Blood and Source Plasma - 02/19/2025

This webinar is intended to provide blood establishments and other stakeholders with an overview of OBRR’s approach to the review of biologics license applications for the manufacture of blood and blood components, including source plasma. In this event, OBRR staff will give presentations on select topics and address questions submitted by registra

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6SoGl7F

December 10, 2024 at 10:00PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/EUW2B6j

December 10, 2024 at 08:56PM FDA Roundup: December 10, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/wA3iy76

December 10, 2024 at 02:36PM Vaccines and Related Biological Products Advisory Committee December 12, 2024 Meeting Announcement - 12/12/2024

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) December 12, 2024 meeting announcement and materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4T3jdrz

Monday, December 9, 2024

December 09, 2024 at 09:56PM VISTASEAL

Fibrin Sealant lead page - FIBRIN SEALANT (Human) is indicated as an adjunct to hemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. FIBRIN SEALANT (Human)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jUtKsVX

Friday, December 6, 2024

December 06, 2024 at 09:08PM FDA Roundup: December 6, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ytSVZcr

December 03, 2024 at 09:52PM FDA Roundup: December 3, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vwM3U74

December 03, 2024 at 03:14PM Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions

Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions


via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Ahc1BUS